Where does ICU Medical's cash flow data come from?

Every line is extracted from ICU Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

ICU Medical ICUI Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Net income	——	-$117.69M-297%	-$29.66M+60.1%	-$74.29M-172%
Depreciation and amortization	$200.74M-8.6%	$219.51M-4.0%	$228.77M-2.7%	$235.15M+162%
Stock-based compensation	$55.76M+18.9%	$46.88M+15.6%	$40.56M+12.6%	$36.03M+31.8%
Amortization of debt issuance costs	$6.18M-9.2%	$6.81M-0.1%	$6.81M-2.3%	$6.97M+2,805%
Gain (loss) on sale of assets	$44.79M—	$0—	$0—	——
Change in accounts receivable	——	$46.84M—	——	$19.15M+239%
Change in inventories	——	——	——	$201.1M+1,066%
Change in accounts payable	——	——	-$68.3M-282%	$37.47M+1,497%
Change in accrued liabilities	——	$20.67M—	——	-$55.83M—
Change in other assets	——	——	-$11.67M+49.0%	-$22.9M-387%
Other working capital changes	$24.47M-25.0%	$32.62M-31.4%	$47.54M+22,417%	-$213K-108%
Net gains (losses) on investments	-$1.19M—	$0—	$0—	——
Non-cash operating lease expense	$17.25M-19.2%	$21.34M-2.6%	$21.91M-7.4%	$23.65M+147%
Loss on extinguishment of debt	-$2.46M—	$0—	$0—	——
Net cash from operating activities	$179.85M-11.9%	$204.03M+21.7%	$167.68M+360%	-$64.44M-124%
Capital expenditures	$88.04M+10.9%	$79.37M-5.4%	$83.89M-7.1%	$90.31M+31.8%
Proceeds from sale of businesses	——	——	$0—	——
Purchases of intangible assets	$8.97M-17.2%	$10.83M+10.8%	$9.78M+8.4%	$9.02M-28.6%
Proceeds from sale of property, plant and equipment	——	$746K-50.3%	$1.5M+51.8%	$989K+354%
Net cash from investing activities	——	-$88.96M-1.2%	-$87.95M+95.4%	-$1.91B-2,006%
Repayments of debt	$302.75M+494%	$51M+71.8%	$29.69M+32.7%	$22.38M—
Proceeds from issuance of common stock	$6.11M-44.2%	$10.94M+172%	$4.02M-54.2%	$8.79M-6.3%
Payments for finance leases	$2.05M+78.6%	$1.15M+19.1%	$963K+41.6%	$680K+12.0%
Taxes paid for net share settlement	——	——	——	——
Net cash from financing activities	-$311.53M-458%	-$55.8M-55.1%	-$35.98M—	——
Effect of exchange rate changes on cash	——	——	$3.25M—	——
Net increase (decrease) in cash	——	$58.29M+28.3%	$45.44M+113%	-$344.04M-320%
Interest paid	$83.74M-16.0%	$99.72M+4.0%	$95.91M+50.5%	$63.71M+7,326%
Amortization expense related to capitalized debt issuance costs	$6.18M-9.2%	$6.81M-0.1%	$6.81M-2.3%	$6.97M+2,805%
Equity in earnings (losses) of equity method investees	-$1.19M—	$0—	$0—	——
Increase (Decrease) in Other Operating Assets	——	$23.15M-6.2%	$24.7M+9.3%	$22.59M+7.4%
Increase (Decrease) in Prepaid Expense and Other Assets	——	——	-$11.67M+49.0%	-$22.9M-387%
Income taxes, including excess tax benefits and deferred income taxes	——	$26.23M+132%	-$82.36M-23.4%	-$66.73M-7,735%
Operating lease right-of-use asset amortization	$17.25M-19.2%	$21.34M-2.6%	$21.91M-7.4%	$23.65M+147%
Other Noncash Income (Expense)	——	——	——	——
Payments to Acquire Intangible Assets	$8.97M-17.2%	$10.83M+10.8%	$9.78M+8.4%	$9.02M-28.6%
Proceeds from the sales of property, plant and equipment	$8.06M+980%	$746K-50.3%	$1.5M+51.8%	$989K+354%
Proceeds from disposals of property, plant and equipment	——	——	——	——
Finance Lease, Principal Payments	$2.05M+78.6%	$1.15M+19.1%	$963K+41.6%	$680K+12.0%
Payment of third-party debt issuance costs	$1.56M—	——	——	——
Accrued payables for capital expenditures	——	$7.98M+21.5%	$6.57M—	——
Direct payoff of a portion of the existing credit facility	$749.69M—	——	——	——
Free cash flow	$100.29M-19.5%	$124.66M—	——	-$152.44M-177%
Free cash flow	$100.29M-19.5%	$124.66M—	——	-$152.44M-177%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does ICU Medical's cash flow data come from?: Every line is extracted from ICU Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.